Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol for prevention of postoperative atrial fibrillation after CABG
IRCT20170620034666N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metoprolol in Atrial fibrillation (AFib) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Postoperative atrial fibrillation incidence, Postoperative blood pressure and 5 more. Started Jun 2020; status: completed.
02
Drugs
metoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20170620034666N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170620034666N3.